Clinical Trial

The Correlation Between CT and MRCP Before Living Liver Donation for Liver Blood Vessel Assessment: an Ambidirectional Cohort Study

Study acronym: BVLDLT
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Living donor liver transplantation (LDLT) is a good solution to the donor liver shortage in the Netherlands. In cases of severe liver disease, LDLT has substantial survival benefits, fewer (future) complications, and an improved quality of life. Donor screening is extensive to minimize risks for both donors and recipients. The liver's blood vessels are assessed using CT and the bile ducts with MRCP. Blood vessel assessment can also be performed using MRCP, which would make the CT unnecessary. Before CT can be removed from the screening procedure, the correlation between blood vessel assessment on CT and MRCP must be clarified. It is hypothesized that CT is equally adequate in assessing liver blood vessels to MRCP.
Trial Details
NCT Number NCT06875232
Lead Sponsor Erasmus Medical Center
Conditions Living Donor Liver Transplantation
Enrollment 90 participants
Start Date 2026-01-01
Primary Completion 2026-11-30 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-13